This will be an open-label, randomized, multicenter, efficacy and safety study of weekly MOD-4023 compared to daily Genotropin therapy in pre-pubertal children with growth hormone deficiency.
Age: 3 - 11 years
Gender: All
We've found 1 total result for "Endocrine System Diseases".